Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
704 (USA) · Dr. Tanaka
consented 2013-01-13
AEs
3
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild HYPERHIDROSIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-30 (study day 18.0); relationship: POSSIBLE
moderate
assessed
Moderate SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-25 (study day 44.0); relationship: NONE
severe
assessed
Severe TRANSIENT ISCHAEMIC ATTACK — outcome: RECOVERED/RESOLVED; onset 2013-02-21 (study day 40.0); relationship: NONE; serious criteria: hospitalization
Data queries
No data queries.